Ecto, founded in 2013, provides workflow management software and analytics to protein producers worldwide. Their software enhances the efficiency and sustainability of protein production, resulting in an additional 51,510,714 healthy servings of protein. With offices in Boston, Atlanta, Stavanger (Norway), and Santiago (Chile), Ecto caters to a global clientele. The company was established at Harvard Innovation Labs by Dmitry Kozachenok, MBA and James Webb, Ph.D. Ecto has garnered research grants from the US National Science Foundation, US Department of Agriculture, and Innovation Norway. Their most recent funding round on 20 October 2023 secured a $560.00KVenture investment. Operating at the intersection of Biotechnology and Information Technology, Ecto is poised for further growth and impact in the protein production industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $560.00K | - | 20 Oct 2023 | |
Series A | $7.00M | 3 | Rabobank Food & Agri Innovation Fund | 01 Oct 2021 |
Series A | $7.21M | 5 | Vodia Ventures, Rabobank | 19 Jul 2021 |
Grant | $225.00K | 1 | 21 Jun 2019 | |
Venture Round | $5.49M | 3 | Vodia Ventures | 26 Oct 2017 |
No recent news or press coverage available for Ecto.